{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:32:08Z","timestamp":1762929128265,"version":"3.41.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,22]]},"DOI":"10.7759\/cureus.84640","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T20:56:21Z","timestamp":1747947381000},"source":"Crossref","is-referenced-by-count":1,"title":["Impact of Multimodal Surgical Resection and Personalized Targeted Therapy on Survival Outcomes in Early-Stage Malignant Pleural Mesothelioma: A Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Alexis Quetzalcoatl","family":"Vega Morales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Luis","family":"Rivera Gastelum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso J","family":"Mass\u00e9 Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis Agustin A","family":"Dunay Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Banda D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Virginia","family":"Rivera Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odalys Brigitte","family":"Villares Santill\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael David","family":"Naranjo Venegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas P","year":"2021","unstructured":"Baas P, Scherpereel A, Nowak AK, et al.. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2021, 397:375-86. 10.1016\/S0140-6736(20)32714-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma Avastin cisplatin pemetrexed study (MAPS): A randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman G","year":"2016","unstructured":"Zalcman G, Mazieres J, Margery J, et al.. Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma Avastin cisplatin pemetrexed study (MAPS): A randomised, controlled, open-label, phase 3 trial. Lancet. 2016, 387:1405-14. 10.1016\/S0140-6736(15)01238-6","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00953-2019","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"55","author":"Scherpereel A","year":"2020","unstructured":"Scherpereel A, Opitz I, Berghmans T, et al.. ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J. 2020, 55:1900953. 10.1183\/13993003.00953-2019","journal-title":"Eur Respir J"},{"key":"ref4","article-title":"Malignant mesothelioma","author":"Syed HA","year":"2025","unstructured":"Syed HA, Wallen JM. Malignant mesothelioma. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients","volume":"10","author":"Taioli E","year":"2015","unstructured":"Taioli E, Wolf AS, Camacho-Rivera M, et al.. Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients. PLoS One. 2015, 10:e0145039. 10.1371\/journal.pone.0145039","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f1903e","article-title":"Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (surveillance, epidemiology, and end results [SEER]) population","volume":"5","author":"Flores RM","year":"2010","unstructured":"Flores RM, Riedel E, Donington JS, et al.. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (surveillance, epidemiology, and end results [SEER]) population. J Thorac Oncol. 2010, 5:1649-54. 10.1097\/JTO.0b013e3181f1903e","journal-title":"J Thorac Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker DJ","year":"1999","unstructured":"Sugarbaker DJ, Flores RM, Jaklitsch MT, et al.. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999, 117:54-65. 10.1016\/S0022-5223(99)70469-1","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-22-199","article-title":"Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach","volume":"11","author":"Klotz LV","year":"2022","unstructured":"Klotz LV, Hoffmann H, Shah R, et al.. Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach. Transl Lung Cancer Res. 2022, 11:2230-42. 10.21037\/tlcr-22-199","journal-title":"Transl Lung Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119165","article-title":"Target therapy in malignant pleural mesothelioma: hope or mirage?","volume":"24","author":"Borea F","year":"2023","unstructured":"Borea F, Franczak MA, Garcia M, et al.. Target therapy in malignant pleural mesothelioma: hope or mirage?. Int J Mol Sci. 2023, 24:9165. 10.3390\/ijms24119165","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.1990.03440100104016","article-title":"Minimizing the three stages of publication bias","volume":"263","author":"Chalmers TC","year":"1990","unstructured":"Chalmers TC, Frank CS, Reitman D. Minimizing the three stages of publication bias. JAMA. 1990, 263:1392-5. 10.1001\/JAMA.1990.03440100104016","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30606-9","article-title":"Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial","volume":"22","author":"Cho BC","year":"2021","unstructured":"Cho BC, Donahoe L, Bradbury PA, et al.. Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial. Lancet Oncol. 2021, 22:190-7. 10.1016\/S1470-2045(20)30606-9","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30095-X","article-title":"Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial","volume":"17","author":"Clive AO","year":"2016","unstructured":"Clive AO, Taylor H, Dobson L, et al.. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial. Lancet Oncol. 2016, 17:1094-104. 10.1016\/S1470-2045(16)30095-X","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot M","year":"2016","unstructured":"de Perrot M, Feld R, Leighl NB, Hope A, Waddell TK, Keshavjee S, Cho BC. Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2016, 151:468-73. 10.1016\/j.jtcvs.2015.09.129","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder W","year":"2007","unstructured":"Weder W, Stahel RA, Bernhard J, et al.. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol. 2007, 18:1196-202. 10.1093\/annonc\/mdm093","journal-title":"Ann Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-2171-8","article-title":"Clinical impact of extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"19","author":"Ambrogi V","year":"2012","unstructured":"Ambrogi V, Baldi A, Schillaci O, Mineo TC. Clinical impact of extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Surg Oncol. 2012, 19:1692-9. 10.1245\/s10434-011-2171-8","journal-title":"Ann Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21261","article-title":"Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"100","author":"Ambrogi V","year":"2009","unstructured":"Ambrogi V, Mineo D, Gatti A, Pompeo E, Mineo TC. Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma. J Surg Oncol. 2009, 100:199-204. 10.1002\/jso.21261","journal-title":"J Surg Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2015.01.058","article-title":"Effects of extended pleurectomy and decortication on quality of life and pulmonary function in patients with malignant pleural mesothelioma","volume":"99","author":"Burkholder D","year":"2015","unstructured":"Burkholder D, Hadi D, Kunnavakkam R, Kindler H, Todd K, Celauro AD, Vigneswaran WT. Effects of extended pleurectomy and decortication on quality of life and pulmonary function in patients with malignant pleural mesothelioma. Ann Thorac Surg. 2015, 99:1775-80. 10.1016\/j.athoracsur.2015.01.058","journal-title":"Ann Thorac Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2012.05.102","article-title":"Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma","volume":"94","author":"Mollberg NM","year":"2012","unstructured":"Mollberg NM, Vigneswaran Y, Kindler HL, Warnes C, Salgia R, Husain AN, Vigneswaran WT. Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma. Ann Thorac Surg. 2012, 94:1086-92. 10.1016\/j.athoracsur.2012.05.102","journal-title":"Ann Thorac Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0218492312454017","article-title":"Changes in lung function after surgery for mesothelioma","volume":"21","author":"Ploenes T","year":"2013","unstructured":"Ploenes T, Osei-Agyemang T, Krohn A, Waller CF, Duncker-Rohr V, Elze M, Passlick B. Changes in lung function after surgery for mesothelioma. Asian Cardiovasc Thorac Ann. 2013, 21:48-55. 10.1177\/0218492312454017","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3666-z","article-title":"Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma","volume":"25","author":"Tanaka T","year":"2017","unstructured":"Tanaka T, Morishita S, Hashimoto M, et al.. Physical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma. Support Care Cancer. 2017, 25:2569-75. 10.1007\/s00520-017-3666-z","journal-title":"Support Care Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel RA","year":"2015","unstructured":"Stahel RA, Riesterer O, Xyrafas A, et al.. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial. Lancet Oncol. 2015, 16:1651-8. 10.1016\/S1470-2045(15)00208-9","journal-title":"Lancet Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure T","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, et al.. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 2011, 12:763-72. 10.1016\/S1470-2045(11)70149-8","journal-title":"Lancet Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5090\/jcs.22.037","article-title":"Survival effect of complete multimodal therapy in malignant pleural mesothelioma","volume":"55","author":"Sayan M","year":"2022","unstructured":"Sayan M, Bas A, Turk MS, Ozkan D, Celik A, Kurul \u0130C, Tastepe AI. Survival effect of complete multimodal therapy in malignant pleural mesothelioma. J Chest Surg. 2022, 55:405-12. 10.5090\/jcs.22.037","journal-title":"J Chest Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5064-4","article-title":"Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"18","author":"Schwartz RM","year":"2018","unstructured":"Schwartz RM, Lieberman-Cribbin W, Wolf A, Flores RM, Taioli E. Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma. BMC Cancer. 2018, 18:1188. 10.1186\/s12885-018-5064-4","journal-title":"BMC Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012605.pub2","article-title":"Radical multimodality therapy for malignant pleural mesothelioma","volume":"1","author":"Abdel-Rahman O","year":"2018","unstructured":"Abdel-Rahman O, Elsayed Z, Mohamed H, Eltobgy M. Radical multimodality therapy for malignant pleural mesothelioma. Cochrane Database Syst Rev. 2018, 1:CD012605. 10.1002\/14651858.CD012605.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/351324-impact-of-multimodal-surgical-resection-and-personalized-targeted-therapy-on-survival-outcomes-in-early-stage-malignant-pleural-mesothelioma-a-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T20:56:22Z","timestamp":1747947382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/351324-impact-of-multimodal-surgical-resection-and-personalized-targeted-therapy-on-survival-outcomes-in-early-stage-malignant-pleural-mesothelioma-a-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.84640","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}